385 related articles for article (PubMed ID: 24401530)
1. Versican and the regulation of cell phenotype in disease.
Wight TN; Kinsella MG; Evanko SP; Potter-Perigo S; Merrilees MJ
Biochim Biophys Acta; 2014 Aug; 1840(8):2441-51. PubMed ID: 24401530
[TBL] [Abstract][Full Text] [Related]
2. Versican and the control of inflammation.
Wight TN; Kang I; Merrilees MJ
Matrix Biol; 2014 Apr; 35():152-61. PubMed ID: 24513039
[TBL] [Abstract][Full Text] [Related]
3. Versican-A Critical Extracellular Matrix Regulator of Immunity and Inflammation.
Wight TN; Kang I; Evanko SP; Harten IA; Chang MY; Pearce OMT; Allen CE; Frevert CW
Front Immunol; 2020; 11():512. PubMed ID: 32265939
[TBL] [Abstract][Full Text] [Related]
4. Proteoglycans in atherosclerosis and restenosis: key roles for versican.
Wight TN; Merrilees MJ
Circ Res; 2004 May; 94(9):1158-67. PubMed ID: 15142969
[TBL] [Abstract][Full Text] [Related]
5. Isolation and Purification of Versican and Analysis of Versican Proteolysis.
Foulcer SJ; Day AJ; Apte SS
Methods Mol Biol; 2022; 2303():559-578. PubMed ID: 34626407
[TBL] [Abstract][Full Text] [Related]
6. Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility.
Ricciardelli C; Russell DL; Ween MP; Mayne K; Suwiwat S; Byers S; Marshall VR; Tilley WD; Horsfall DJ
J Biol Chem; 2007 Apr; 282(14):10814-25. PubMed ID: 17293599
[TBL] [Abstract][Full Text] [Related]
7. Isolation and purification of versican and analysis of versican proteolysis.
Foulcer SJ; Day AJ; Apte SS
Methods Mol Biol; 2015; 1229():587-604. PubMed ID: 25325983
[TBL] [Abstract][Full Text] [Related]
8. Defining the versican interactome in lung health and disease.
Tang F; Brune JE; Chang MY; Reeves SR; Altemeier WA; Frevert CW
Am J Physiol Cell Physiol; 2022 Aug; 323(2):C249-C276. PubMed ID: 35649251
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of cardiomyocytes from human embryonic stem cells is accompanied by changes in the extracellular matrix production of versican and hyaluronan.
Chan CK; Rolle MW; Potter-Perigo S; Braun KR; Van Biber BP; Laflamme MA; Murry CE; Wight TN
J Cell Biochem; 2010 Oct; 111(3):585-96. PubMed ID: 20564236
[TBL] [Abstract][Full Text] [Related]
10. Structure, function and regulation of versican: the most abundant type of proteoglycan in the extracellular matrix.
Sotoodehnejadnematalahi F; Burke B
Acta Med Iran; 2013; 51(11):740-50. PubMed ID: 24390942
[TBL] [Abstract][Full Text] [Related]
11. Versican in health and disease.
Theocharis AD
Connect Tissue Res; 2008; 49(3):230-4. PubMed ID: 18661349
[TBL] [Abstract][Full Text] [Related]
12. The inflammatory oxidant peroxynitrous acid modulates the structure and function of the recombinant human V3 isoform of the extracellular matrix proteoglycan versican.
Jørgensen SM; Lorentzen LG; Hammer A; Hoefler G; Malle E; Chuang CY; Davies MJ
Redox Biol; 2023 Aug; 64():102794. PubMed ID: 37402332
[TBL] [Abstract][Full Text] [Related]
13. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells.
Evanko SP; Angello JC; Wight TN
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1004-13. PubMed ID: 10195929
[TBL] [Abstract][Full Text] [Related]
14. Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion.
Potter-Perigo S; Johnson PY; Evanko SP; Chan CK; Braun KR; Wilkinson TS; Altman LC; Wight TN
Am J Respir Cell Mol Biol; 2010 Jul; 43(1):109-20. PubMed ID: 19717812
[TBL] [Abstract][Full Text] [Related]
15. Versican/PG-M Assembles Hyaluronan into Extracellular Matrix and Inhibits CD44-mediated Signaling toward Premature Senescence in Embryonic Fibroblasts.
Suwan K; Choocheep K; Hatano S; Kongtawelert P; Kimata K; Watanabe H
J Biol Chem; 2009 Mar; 284(13):8596-604. PubMed ID: 19164294
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk Between T Lymphocytes and Lung Fibroblasts: Generation of a Hyaluronan-Enriched Extracellular Matrix Adhesive for Monocytes.
Gaucherand L; Falk BA; Evanko SP; Workman G; Chan CK; Wight TN
J Cell Biochem; 2017 Aug; 118(8):2118-2130. PubMed ID: 27982477
[TBL] [Abstract][Full Text] [Related]
17. Context-dependent bioactivity of versican fragments.
Timms KP; Maurice SB
Glycobiology; 2020 May; 30(6):365-373. PubMed ID: 31651027
[TBL] [Abstract][Full Text] [Related]
18. Provisional matrix: A role for versican and hyaluronan.
Wight TN
Matrix Biol; 2017 Jul; 60-61():38-56. PubMed ID: 27932299
[TBL] [Abstract][Full Text] [Related]
19. Versican in inflammation and tissue remodeling: the impact on lung disorders.
Andersson-Sjöland A; Hallgren O; Rolandsson S; Weitoft M; Tykesson E; Larsson-Callerfelt AK; Rydell-Törmänen K; Bjermer L; Malmström A; Karlsson JC; Westergren-Thorsson G
Glycobiology; 2015 Mar; 25(3):243-51. PubMed ID: 25371494
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration.
Evanko SP; Potter-Perigo S; Bollyky PL; Nepom GT; Wight TN
Matrix Biol; 2012 Mar; 31(2):90-100. PubMed ID: 22155153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
